These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 539879

  • 1. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M, Sich M, Habib R.
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [Abstract] [Full Text] [Related]

  • 2. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R, Lévy M, Gubler MC, Broyer M, Habib M.
    Arch Fr Pediatr; 1977 Nov; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [Abstract] [Full Text] [Related]

  • 3. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y, Ohi H, Watanabe S, Seki M, Hatano M.
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [Abstract] [Full Text] [Related]

  • 4. [Direct detection C3bBb stabilizing activity in sera from hypocomplementaemic membranoproliferative glomerulonephritis (MPGN) and complement profiles of C3NeF positive cases].
    Watanabe S, Ohi H, Seki M, Fujita T, Hatano M.
    Nihon Jinzo Gakkai Shi; 1985 Oct; 27(10):1345-52. PubMed ID: 4094159
    [No Abstract] [Full Text] [Related]

  • 5. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M, Balow JE, Tsokos GC.
    J Immunol; 1986 Jun 15; 136(12):4451-5. PubMed ID: 3011894
    [Abstract] [Full Text] [Related]

  • 6. [Morphological varieties of membranoproliferative glomerulonephritis].
    Imbasciati E, Tarantino A, Ponticelli C, Giani M, Bardare M, Gaboardi F.
    Minerva Nefrol; 1981 Jun 15; 28(3):415-9. PubMed ID: 7329619
    [No Abstract] [Full Text] [Related]

  • 7. [Complement activating factors in hypocomplementemic membranoproliferative glomerulonephritis (MPGN) patients' sera--comparison with C3NeF positive and negative cases].
    Ohmori F, Ohi H, Seki M, Watanabe S, Hatano M.
    Nihon Jinzo Gakkai Shi; 1987 Apr 15; 29(4):493-8. PubMed ID: 3656707
    [No Abstract] [Full Text] [Related]

  • 8. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP, Pertosa G, Stanziale P, Vox E, Pecoraro C, Andreucci VE.
    Clin Nephrol; 1982 Nov 15; 18(5):240-6. PubMed ID: 7151338
    [Abstract] [Full Text] [Related]

  • 9. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC, Peters DK.
    Clin Exp Immunol; 1986 Aug 15; 65(2):450-7. PubMed ID: 3641695
    [Abstract] [Full Text] [Related]

  • 10. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E, Yagüe J, Vives J, Revert L.
    Med Clin (Barc); 1981 Jun 10; 77(1):21-6. PubMed ID: 7253758
    [Abstract] [Full Text] [Related]

  • 11. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE, Ng YC, Peters DK, Lea T, Tschopp J, Harboe M.
    Clin Exp Immunol; 1986 Jul 10; 65(1):73-9. PubMed ID: 3641694
    [Abstract] [Full Text] [Related]

  • 12. Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
    Daha MR, Van Es LA.
    Neth J Med; 1982 Jul 10; 25(7):202-7. PubMed ID: 6924073
    [No Abstract] [Full Text] [Related]

  • 13. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F.
    J Med Genet; 2007 Mar 10; 44(3):193-9. PubMed ID: 17018561
    [Abstract] [Full Text] [Related]

  • 14. Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).
    Ohi H, Yasugi T.
    Clin Exp Immunol; 1994 Feb 10; 95(2):316-21. PubMed ID: 8306508
    [Abstract] [Full Text] [Related]

  • 15. Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation.
    Jackson EC, McAdams AJ, Strife CF, Forristal J, Welch TR, West CD.
    Am J Kidney Dis; 1987 Feb 10; 9(2):115-20. PubMed ID: 3826060
    [Abstract] [Full Text] [Related]

  • 16. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
    Davis BK, Cavallo T.
    Am J Pathol; 1976 Aug 10; 84(2):283-98. PubMed ID: 133617
    [Abstract] [Full Text] [Related]

  • 17. A case of hypocomplementemic mesangiocapillary glomerulonephritis: appearance of C3 NeF and another factor.
    Seki M, Ohi H, Watanabe S, Kojima H, Fujita T, Hatano M.
    Nihon Jinzo Gakkai Shi; 1987 May 10; 29(5):585-8. PubMed ID: 3656714
    [No Abstract] [Full Text] [Related]

  • 18. [Complement levels in children with idiophatic nephrotic syndrome (author's transl)].
    Pölz E, Lubec G.
    Padiatr Padol; 1977 May 10; 12(4):360-4. PubMed ID: 409980
    [Abstract] [Full Text] [Related]

  • 19. Detection of C3bBb-stabilizing activity (C3 nephritic factor) in the serum from patients with membranoproliferative glomerulonephritis.
    Ohi H, Watanabe S, Fujita T, Seki M, Hatano M.
    J Immunol Methods; 1990 Jul 20; 131(1):71-6. PubMed ID: 2380570
    [Abstract] [Full Text] [Related]

  • 20. C5 measurement in membranoproliferative glomerulonephritis patients with C3 nephritic factor.
    Ohi H, Watanabe S, Seki M, Fujita T, Ohmori F, Hatano M.
    Nephron; 1987 Jul 20; 46(2):217-8. PubMed ID: 3600936
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.